You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11. Distribution of clients entering treatment according to age at first use of primary drug and primary drug - EU overall summary in 2005 [see all tables in this series...]

Part (i) Distribution of new outpatient clients by age group for each primary drug

Substance	<15	15-19	20-24	25-29	30-34	35-39	40-44	45+	Mean age	Age known (base)	Age not known
Opiates	5.4	39.9	29.7	12.4	6.6	3.3	1.8	0.8	22.4	21162	7352
Cocaine	6.2	42.1	26.4	12.8	6.3	3.8	1.5	1.0	22.2	22750	5767
Stimulants	12.3	63.7	16.4	4.9	1.6	0.8	0.2	0.1	18.8	6315	1536
Hypnotics and sedatives	6.6	24.5	16.1	11.8	11.7	7.3	5.9	16.2	29.2	1570	386
Hallucinogens	14.5	64.2	16.8	2.8	1.0	0.1	0.5	0.1	18.4	1020	232
Volatile substances	50.6	42.5	4.9	0.4	1.2	0.0	0.0	0.4	16.1	247	24
Cannabis	33.2	54.9	8.3	2.1	0.8	0.4	0.2	0.1	17.1	23477	8725
Other substances	14.0	50.1	15.5	7.8	5.1	0.6	4.8	2.2	21.4	692	363
Total	15.0	47.1	20.5	8.6	4.3	2.4	1.2	0.9	20.5	77233	24385

Notes:

Countries reporting data: BG, CZ, DK, DE, IE, EL, ES, FR, IT, CY, LV, MT, NL, SK, FI, SE

Last data available from Spain refer to 2004

The number of treatment clients in each country is listed in [Table TDI-7].

See also ''TDI-106-New outpatient age at first use and primary drug.xls'' on distribution by country and ''General notes for interpreting data'' on the Explanatory notes and help page.

Sources:

2006 Reitox national reports - Table TDI outpatient treatment centres